Serological testing for Lyme borreliosis was compared in 5 European re
ference laboratories with a total of 79 sera in order to determine var
iations in laboratory performance. A considerable range of methods wer
e used and several laboratories employed 2 or 3 genomospecies of Borre
lia burgdorferi sensu late. No laboratory relied routinely on a single
test and each weighted the significance of the findings of the variou
s tests differently A difference in strategy between laboratories in h
igh and low prevalence areas was apparent in that laboratories in low
prevalence areas emphasised specificity more than sensitivity and ther
efore produced fewer false positives, but also missed some cases. Over
all agreement between the laboratories was poor and it was concluded t
hat there is a need for a quality assurance scheme within Europe.